Protein Aggregates and Aggrephagy in Myopathies

Area of Science:

• Cellular Biology
• Molecular Biology
• Muscle Physiology

Background:

• Many muscular disorders involve the accumulation of misfolded proteins within muscle fibers.
• Aggrephagy, a specialized form of macroautophagy, is crucial for clearing these protein aggregates.
• Key proteins like p62, NBR1, Alfy, Tollip, Optineurin, TAX1BP1, and CCT2 are central to the aggrephagy pathway.

Purpose of the Study:

• To review the current understanding of aggrephagy's role in muscular diseases.
• To summarize the involvement and activation of key aggrephagy players in muscle disorders.
• To highlight the link between aggrephagy pathway dysfunction and the pathogenesis of protein aggregate-associated myopathies.

Main Methods:

• Literature review of studies on aggrephagy and muscular disorders.
• Description of the aggrephagy pathway and its molecular components.
• Histological and molecular analysis of muscle disorders characterized by protein aggregates.

Main Results:

• Aggrephagy is a critical mechanism for removing toxic protein aggregates in muscle cells.
• Abnormalities in the aggrephagy pathway, including the dysfunction of key proteins, are implicated in the development and progression of various muscular diseases.
• Specific muscular disorders exhibit characteristic protein aggregate accumulation due to impaired aggrephagy.

Conclusions:

• The aggrephagy pathway and its key protein players are directly involved in the pathogenesis of muscular disorders characterized by protein aggregation.
• Understanding aggrephagy dysfunction offers potential therapeutic targets for treating these debilitating muscle diseases.